首页> 美国卫生研究院文献>Frontiers in Public Health >Are There Striking Differences in Outpatient Use of Antibiotics Between South Backa District Serbia and Some Scandinavian Countries?
【2h】

Are There Striking Differences in Outpatient Use of Antibiotics Between South Backa District Serbia and Some Scandinavian Countries?

机译:南Backa区塞尔维亚和一些斯堪的纳维亚国家之间在门诊使用抗生素方面有显着差异吗?

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

There is little published information about antibiotic utilization in outpatients in Serbia. The objective of this study was to determine the amount and structure of outpatient antibiotic use in South Backa District (SBD) in Serbia, to assess prescibing quality of antibiotics and to compare with results from Scandinavian countries. Data on the antibiotic use were collected from all private and state-owned pharmacies from January through March 2008 in SBD. Results were expressed as the number of defined daily doses/1,000 inhabitants/day. The drug utilization 90% method was also used. Penicillins were the most frequently used antibiotic subgroup in SBD (35.20%), followed by cephalosporins (19.16%) and macrolides (13.18%). Thirteen drugs accounted for 90% of total antibiotics consumption (DU90% segment). The average cost/DDD within the DU90% segment was 0.95 euros, whereas the average cost/DDD beyond the DU90% segment was 1.89 euros, indicating that less expensive antibiotics were more frequently used. High use of ampicillin, third-generation cefalosporins, co-trimoxazole, and gentamicin, will aggravate the alarming problem of resistance in Serbia. Differences in the amount and structure of antibiotic consumption between SBD and Scandinavian countries indicate the need of updated national guidelines for rational antimicrobial drug use in Serbia.
机译:关于塞尔维亚门诊病人使用抗生素的信息很少。这项研究的目的是确定塞尔维亚南Backa区(SBD)门诊使用抗生素的数量和结构,评估抗生素的处方质量,并与斯堪的纳维亚国家的结果进行比较。从2008年1月至2008年3月在SBD的所有私营和国有药房收集了有关抗生素使用的数据。结果表示为规定的日剂量/ 1,000居民/天。还使用了90%的药物利用率方法。青霉素是SBD中最常用的抗生素亚类(35.20%),其次是头孢菌素(19.16%)和大环内酯类(13.18%)。十三种药物占抗生素总消费量的90%(DU90%细分市场)。 DU90%细分市场的平均成本/ DDD为0.95欧元,而DU90%细分市场以外的平均成本/ DDD为1.89欧元,表明更便宜的抗生素被更频繁地使用。大量使用氨苄西林,第三代头孢菌素,复方新诺明和庆大霉素,将加剧塞尔维亚令人担忧的耐药性问题。 SBD和斯堪的纳维亚国家之间抗生素消费量和结构的差异表明,有必要更新塞尔维亚合理使用抗生素的国家准则。

著录项

相似文献

  • 外文文献
  • 中文文献
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号